Skip to main content

Table 1 Baseline characteristics of total patients

From: Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study

Characteristics

Normal ALT (n = 74)

Mildly elevated ALT (n = 54)

p value

Age (yr)

41.7 ± 9.2

41.7 ± 9.9

0.989

Male, n, %

44 (59.5%)

42 (77.8%)

0.029

ALT (U/L)

25.39 ± 9.03

67.35 ± 20.56

0.000

AST (U/L)

24.71 ± 8.25

41.94 ± 18.00

0.000

ALB (g/L)

45.25 ± 5.69

44.64 ± 5.39

0.592

TBil (μmol/L)

12.65 ± 5.55

12.53 ± 6.39

0.926

DBil (μmol/L)

4.52 ± 2.15

4.71 ± 2.85

0.700

WBC (× 109/L)

6.31 ± 1.69

6.15 ± 1.25

0.603

LYM (× 109/L)

2.04 ± 0.59

2.12 ± 0.62

0.534

PLT (× 109/L)

214.4 ± 49.38

199.8 ± 56.23

0.197

HGB (g/L)

144.2 ± 17.95

151.06 ± 13.08

0.053

HBV DNA (log10IU/mL)

4.66 ± 1.18

5.33 ± 1.74

0.016

HBsAg (log10IU/mL)

3.07 ± 0.63

3.14 ± 0.66

0.589

AFP (ng/mL)

3.37 ± 1.87

4.34 ± 3.44

0.147

LSM (kPa)

7.34 ± 2.31

8.22 ± 3.30

0.207

  1. Continuous data are expressed as the mean ± SD
  2. ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBil, total bilirubin; DBil, direct bilirubin; WBC, white blood cell; LYM, lymphocyte; PLT, platelet; HGB, hemoglobin; HBV, hepatitis B virus; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; AFP, alpha-fetoprotein; LSM, liver stiffness measurement